| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 800.0K | $1.03M | - | |
| Other | 400.0K | $516.0K | - | |
| Other | 30.0K | $38.7K | - | |
| Dir | 29.8K | $38.4K | - | |
| Dir | 29.2K | $37.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | Guerrero Ramiro | Director | Buy | 1,500 | $3.98 | $5,970.00 | +0.3% | -38.2% | -66.8% | |
| Mar 9, 2023 | Smith Stan | Director | Buy | 3,582 | $4.03 | $14,435.46 | +0.7% | -41.1% | -66.8% | |
| Mar 9, 2023 | Luput Cristian | Director | Buy | 2,741 | $4.03 | $11,059.66 | +0.5% | -41.1% | -66.8% | |
| Mar 8, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,581 | $4.21 | $6,656.01 | +0.2% | -41.5% | -65.9% | |
| Mar 8, 2023 | Smith Stan | Director | Buy | 5,037 | $4.21 | $21,214.23 | +0.5% | -41.5% | -65.9% | |
| Mar 7, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,983 | $4.24 | $8,407.92 | +0.1% | -45.3% | -65.8% | |
| Mar 7, 2023 | Luput Cristian | Director | Buy | 2,215 | $4.23 | $9,374.72 | +0.4% | -45.3% | -65.8% | |
| Mar 7, 2023 | Guerrero Ramiro | Director | Buy | 1,352 | $4.25 | $5,741.19 | +0.2% | -45.3% | -65.8% | |
| Mar 6, 2023 | Smith Stan | Director | Buy | 7,103 | $4.40 | $31,282.53 | +0.7% | -47.8% | -67.1% | |
| Mar 3, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 2,443 | $4.47 | $10,917.96 | +0.2% | -44.1% | -69.7% |